BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30030270)

  • 1. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
    Martínez-Laperche C; Buces E; Aguilera-Morillo MC; Picornell A; González-Rivera M; Lillo R; Santos N; Martín-Antonio B; Guillem V; Nieto JB; González M; de la Cámara R; Brunet S; Jiménez-Velasco A; Espigado I; Vallejo C; Sampol A; Bellón JM; Serrano D; Kwon M; Gayoso J; Balsalobre P; Urbano-Izpizua Á; Solano C; Gallardo D; Díez-Martín JL; Romo J; Buño I;
    Blood Adv; 2018 Jul; 2(14):1719-1737. PubMed ID: 30030270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
    Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
    Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.
    Guillem V; Hernández-Boluda JC; Gallardo D; Buño I; Bosch A; Martínez-Laperche C; de la Cámara R; Brunet S; Martin C; Nieto JB; Martínez C; Pérez A; Montoro J; Garcia-Noblejas A; Solano C;
    Am J Hematol; 2013 Oct; 88(10):883-9. PubMed ID: 23813863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
    Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
    Santos N; Rodríguez-Romanos R; de la Cámara R; Brunet S; Nieto JB; Buño I; Martínez C; Jiménez-Velasco A; Vallejo C; González M; Solano C; Ferrá C; Sampol A; Pérez-Simón JA; López-Jiménez J; Díez JL; Gallardo D;
    Ann Hematol; 2018 Nov; 97(11):2217-2224. PubMed ID: 30019128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
    Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM
    Bone Marrow Transplant; 2017 Jan; 52(1):88-94. PubMed ID: 27376453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
    Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M; Ayas M; Bitan M; Cairo M; Choi SW; Dandoy C; Delgado D; Gale RP; Hale G; Frangoul H; Kamble RT; Kharfan-Dabaja M; Lehman L; Levine J; MacMillan M; Marks DI; Nishihori T; Olsson RF; Hematti P; Ringden O; Saad A; Satwani P; Savani BN; Schultz KR; Seo S; Shenoy S; Waller EK; Yu L; Horowitz MM; Horan J
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):521-528. PubMed ID: 29155316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and Risk Factors of Relapse after Allogeneic Stem Cell Transplantation in Children with Leukemia: A Long-Term Follow-Up Single-Center Study.
    Molina B; Gonzalez Vicent M; Herrero B; Deltoro N; Ruiz J; Perez Martinez A; Diaz MA
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):100-106. PubMed ID: 30142415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
    Granero Farias M; Andrade Dos Santos C; de Mello Vicente B; Habigzang M; de Oliveira da Silva P; Emerim Lemos N; Dieter C; Paz A; Esteves Daudt L
    Hum Immunol; 2020 Jan; 81(1):18-25. PubMed ID: 31889553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
    Takahashi H; Furukawa T; Hashimoto S; Suzuki N; Kuroha T; Yamazaki F; Inano K; Takahashi M; Aizawa Y; Koike T
    Bone Marrow Transplant; 2000 Dec; 26(12):1317-23. PubMed ID: 11223972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of the outcome after second or subsequent allogeneic transplantation.
    Kedmi M; Resnick IB; Dray L; Aker M; Samuel S; Gesundheit B; Slavin S; Or R; Shapira MY
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):483-9. PubMed ID: 19285636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
    Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation.
    Mlynarczewska A; Wysoczanska B; Karabon L; Bogunia-Kubik K; Lange A
    Bone Marrow Transplant; 2004 Aug; 34(4):339-44. PubMed ID: 15235581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
    Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
    Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2019 May; 98(5):1267-1277. PubMed ID: 30747249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
    Pérez-Simón JA; Díez-Campelo M; Martino R; Brunet S; Urbano A; Caballero MD; de León A; Valcárcel D; Carreras E; del Cañizo MC; López-Fidalgo J; Sierra J; San Miguel JF
    Br J Haematol; 2005 Aug; 130(3):394-403. PubMed ID: 16042689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Remberger M; Kumlien G; Aschan J; Barkholt L; Hentschke P; Ljungman P; Mattsson J; Svennilson J; Ringdén O
    Biol Blood Marrow Transplant; 2002; 8(12):674-82. PubMed ID: 12523580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.